Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Misoprostol-Only Regimen Evidence (MORE) Study: A Randomized Controlled Trial Comparing the Misoprostol-only Regimen Versus the Combined Mifepristone and Misoprostol Regimen for Medication Abortion

NCT07174856 is registered in ClinicalTrials.gov with Ibis Reproductive Health as lead sponsor.

NCT NCT07174856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Misoprostol-Only Regimen Evidence (MORE) Study: A Randomized Controlled Trial Comparing the Misoprostol-only Regimen Versus the Combined Mifepristone and Misoprostol Regimen for Medication Abortion
Lead sponsor
Ibis Reproductive Health
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 10, 2025
Completion date
March 31, 2027
Enrollment
1,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, medical